ENES ÇELİK

ENES ÇELİK

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2021 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
EAEkrem Aksu
Ekrem Aksu
BCBilal Cuglan
Bilal Cuglan
ATabdullah tok
abdullah tok
EÇENES ÇELİK
ENES ÇELİK
ADAdem Doğaner
Adem Doğaner
GSGulizar Sokmen
Gulizar Sokmen
Preeclampsia increases the risk of cardiovascular mortality and morbidity both during pregnancy and long term after the labor by causing cardiac changes that may lead to atrial and ventricular arrh...

1 November 2022 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
ABAkif Serhat Balcioglu
Akif Serhat Balcioglu
EÇENES ÇELİK
ENES ÇELİK
MSMurat Sahin
Murat Sahin
KGKemal Göçer
Kemal Göçer
EAEkrem Aksu
Ekrem Aksu
AAAhmet Cagri Aykan
Ahmet Cagri Aykan
Cardiac autonomic neuropathy,dapagliflozin,heart rate variability,SGLT2 inhibitors,turbulence

27 July 2020 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
HGHatice Güneş
Hatice Güneş
HGHakan Güneş
Hakan Güneş
ŞÖŞebnem Özmen
Şebnem Özmen
EÇENES ÇELİK
ENES ÇELİK
FTFatih Temiz
Fatih Temiz
Introduction: Obesity is usually related to insulin resistance and glucose metabolism disorders. The relationship between insulin resistance and epicardial adipose tissue and atrial electromechanical delay has been described in previous studies.Aim: This study aims to demonstrate the effects of metformin on epicardial adipose tissue and electromechanical delay in patients using metformin for insulin resistance.Materials and methods: A total of 30 patients using metformin for insulin resistance were included in the study. Pre-treatment and post-treatment epicardial adipose tissue and electromechanical delay were evaluated.Results: There was a statistically significant decrease in epicardial adipose tissue thickness after 3 months of metformin therapy (6.4 ± 2.1 versus 4.7 ± 2.0; p = 0.008). Furthermore, the inter-atrial and intra-atrial electromechanical delay also significantly decreased after 3 months of metformin monotherapy (23.6 ± 8.2 versus 18.1 ± 5.8; p < 0.001, 9.1 ± 2.9 versus 6.3 ± 3.6; p = 0.003, respectively).Conclusion: In this study, we show that metformin monotherapy significantly decreases epicardial adipose tissue thickness and electromechanical delay in obese children.

24 February 2025 in Cardiovascular Toxicology
Verified
Journal Article
Open access
PDF file
MKMustafa Kaplangoray
Mustafa Kaplangoray
KTKenan Toprak
Kenan Toprak
CCCuneyt Caglayan
Cuneyt Caglayan
EDEdhem Deveci
Edhem Deveci
EÇENES ÇELİK
ENES ÇELİK
CACihan Aydın
Cihan Aydın
Systemic inflammatory response index (SIRI), is associated with prognosis in coronary artery disease (CAD), heart failure (HF), and acute myocardial infarction. This study investigated the relationship between SIRI and non-dipper hypertension. The study retrospectively included a total of 254 naive, newly diagnosed hypertensive individuals based on ambulatory blood pressure monitoring (ABPM), containing 166 dippers (DHT) and 88 non-dippers (NDHT). The SIRI value of all patients was calculated based on neutrophil, monocyte, and lymphocyte counts. The average age of study population was 50.7 ± 9.4 years old, and the male ratio was 68.5%. Compared with DHT, patients in the NDHT group had higher SIRI, monocyte to HDL-C ratio (MHR), neutrophil–lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), C-reactive protein (CRP), and neutrophil count, while high-density lipoprotein cholesterol (HDL-C) and lymphocyte count were lower (p < 0.05). The left ventricular mass index (LVMI) was higher in the NDHT group (p < 0.05). Multivariate logistic regression analysis showed that SIRI, LVMI, and HDL-C were independent predictor factors for NDHT. ROC curve analysis determined the optimal SIRI cut-off value for predicting NDHT diagnosis to be 2.41 (sensitivity 69.3%, specificity 64.5%, area under the receiver operating characteristic curve, 0.743; p < 0.001). The AUC values obtained for SIRI, MHR, NLR, PLR, HDL-C, and LVMI parameters in the ROC curve analysis were compared pairwise. The results demonstrated that SIRI’s discriminative capacity in predicting NDHT was superior to all other indices. SIRI is an independent and significant predictor factor for NDHT and is superior in predicting NDHT diagnosis compared with HDL-C, MHR, LVMI, NLR, and PLR. Graphical Abstract Relationship between SIRI and non-dipper hypertension. Can inflammation-based hematological parameters serve as an alternative to ambulatory blood pressure monitoring in the diagnosis of non-dipper hypertension? LAd Left Atrium Diameter; HDL-C High-Density Lipoprotein Cholesterol; LDL-C Low-Density Lipoprotein Cholesterol; NLR Neutrophil/Lymphocyte Ratio; PLR Platelet/Lymphocyte Ratio; SIRI Systemic İnflammatory Response İndex; LVMI Left Ventricular Mass İndex; MHR Monocyte To Hdl-C Ratio

23 June 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
EAEkrem Aksu
Ekrem Aksu
EBEjder Berk
Ejder Berk
ASAbdullah Sökmen
Abdullah Sökmen
GSGülizar Sökmen
Gülizar Sökmen
EÇENES ÇELİK
ENES ÇELİK
Background/aim: In the literature, there is a paucity of data about the effects of fibromyalgia syndrome (FMS) on myocardial function and electrophysiological properties of atrium and ventricles. In this study, we investigated cardiac functions and noninvasive predictors of arrhythmias in patients with FMS. Materials and methods: The study included 43 female patients diagnosed with FMS and 30 age- and sex-matched healthy subjects. The presence of fragmented QRS (fQRS) morphology, P dispersion, QT dispersion, inter- and intraatrial electromechanical delay was evaluated in the groups with 12-lead ECG and standard and tissue Doppler echocardiography. Results: Among electrocardiographic parameters, P dispersion, QT dispersion, and the ratio of presence of fQRS morphology were found to be significantly higher in the study group as compared to the control group. In lateral and septal, the ratio of the early transmitral flow velocity to the early diastolic tissue velocity (E/Em) was significantly higher in the study group. Additionally, intra- and interatrial electromechanical delay was found significantly prolonged in the study group. Conclusion: FMS is found to be associated with significant cardiac electrical alterations that may indicate the increased risk of atrial and ventricular arrhythmias in this group of patients.

1 January 2024 in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Verified
Journal Article
Closed access
EÇENES ÇELİK
ENES ÇELİK
Objective: This study aims to explore the impact of sodium-glucose cotransporter-2 (SGLT-2) inhibitors, a newer class of oral antidiabetic drugs, on atrial electromechanical delay (EMD) in patients with type 2 diabetes mellitus (DM). This is particularly relevant given the significantly higher incidence of atrial fibrillation (AF) in diabetic patients compared to the general population. Atrial electromechanical delay is recognized as an important factor influencing the development of atrial fibrillation. Methods: This study included 30 type 2 DM patients (53.3% female, mean age 60.07 +/- 10.03 years), initiating treatment with SGLT-2 inhibitors. The patients were assessed using echocardiography at baseline and again at 6 months, focusing on basic echocardiographic parameters and atrial electromechanical delay times (EMD) measured via tissue Doppler imaging. Results: No significant changes were observed in intra-atrial EMD times. However, significant reductions were noted in interatrial EMD times, decreasing from 15.13 +/- 5.87 ms to 13.20 +/- 6.12 ms (P = 0.029). Statistically significant shortening occurred in lateral pulmonary acceleration (PA) times (from 58.73 +/- 6.41 ms to 54.37 +/- 6.97 ms, P < 0.001), septal PA times (from 50.90 +/- 6.02 ms to 48.23 +/- 5), and tricuspid PA times (from 43.60 +/- 6.28 ms to 41.30 +/- 5.60 ms, P = 0.003). Additionally, there was a significant reduction in the E/e' ratio from 8.13 +/- 4.0 to 6.50 +/- 2.37 (P = 0.003). Conclusion: SGLT-2 inhibitors might positively influence atrial electromechanical conduction, reducing DM-related functional impairments and the risk of arrhythmias, particularly AF.